AI assistant
Sending…
Sanara MedTech Inc. — Director's Dealing 2012
Jun 11, 2012
33339_dirs_2012-06-11_0d3b05ea-e837-45b4-bd51-a8018e2828dc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: WOUND MANAGEMENT TECHNOLOGIES, INC. (wndm)
CIK: 0000714256
Period of Report: 2012-03-20
Reporting Person: Lutz Robert Jr. (Director, President and CEO)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock $.001 par value | 250000 | Indirect |
Footnotes
F1: The reporting person disclaims beneficial ownership of these securities, and the reporting of these securities herein shall not be deemed an admission of ownership of these securities for the purposes of Section 16 of the Exchange Act or for any other purpose.
More from Sanara MedTech Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 11
Proxy Solicitation & Information Statement
2026
Apr 17
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Major Shareholding Notification
2026
Apr 14
Annual Report
2026
Mar 24
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 23